Answers are grounded in this paper and cite their sources.
Purpose Duodenal atresia (DA) is known to be strongly linked with trisomy 21 and to cardiac anomalies. However, risk factors for non-genetic DA remain largely unknown. Hence, we set out to identify maternal risk factors for this anomaly. Methods All DA cases (n = 249) in 2004–2017 were identified in the Finnish Register of Congenital Malformations. After exclusion of the genetic cases (n = 83), five matched controls for each DA case (n = 166 and n = 830) were randomly selected. Analyzed maternal risk factors were maternal chronic diseases, prescription drugs dispensed during the first trimester of pregnancy, smoking, BMI, and reproductive history. Results In multivariable analysis, only primiparity was observed as an independent risk factor (adjusted OR 1.63, 95% CI 1.13–2.35). Antihistamines (ATC-code R06AX) emerged with a potential but inconclusive signal (aOR 3.50, 95% CI 0.91–13.5). Maternal pregestational diabetes (OR 1.68, 95% CI 0.60–4.71), smoking (OR 1.36, 95% CI 0.83–2.22) or BMI (OR 0.55, 95% CI 0.16–1.85 for underweight; OR 0.84, 95% CI 0.57–1.24 for overweight) were not associated with DA. Conclusions In our data, only primiparity was associated with non-genetic DA. This and sparsity of previous studies for non-genetic DA highlights the need for future research with higher case numbers.
No takes yet. Share an insight, caveat, or question.
Alikärri et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: